# Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell Carcinoma

> clinical trial · VERIFIED · 2026-08-20

Status: NOT_YET_RECRUITING · Sponsor: West China Hospital · Condition: Non-Clear Cell Renal Cell Carcinoma

- Company: West China Hospital
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07776483

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.